Design, Fabrication and Characterization of Multiscale and Multifunctional Biomaterials 1

About

Design, Fabrication and Characterization of Multiscale and Multifunctional Biomaterials: The ability to engineer biomaterials at the molecular, micro and macro scales provides new opportunities to design and fabricate multiscale systems that can interact with cells and tissues by integrating physical, mechanical and chemical mechanisms. This session welcomes submissions focused on new design strategies for these types of biomaterials, novel fabrication approaches from the nano to micro to macro scales, and methods used to characterize cell and tissue response.

Abstracts

Cardiovascular Biomaterials

Abstracts

Thought Leader Symposium - Frederick J. Schoen, MD, PhD: Understanding, Reacting to, and Preventing Medical Device Failure

Abstracts

Invited Speaker(s)

  • Frederick J. Schoen, MD, PhD
  • Richard Bianco
  • Cynthia Claque
  • Ann Graves
  • Stuart Goodman, MD, PhD

Orthopaedic Biomaterials 3

Abstracts

Invited Speaker(s)

Tissue Engineering and Organoid Development

Abstracts

Invited Speaker(s)

*BTI*Panel Discussion: Benchtop to Bedside: We’ll Get You There! - Packaging and Sterilization Methods that Withstand Regulatory Scrutiny

About

A panel of industry and packaging/sterilization specialists who can take the audience through the considerations of packaging and sterilization for clinical trials and commercial distribution. Discussion of international standards and US-FDA Guidances that can help provide direction to product development, manufacturing, and quality systems. The panel will discuss the advantages and pitfalls of different sterilization methods and validation strategies. The panel will discuss key considerations in determining which sterilization methods to consider based on product. The panel will explore the future directions of packaging and sterilization and how new technology can fit into and break the mold of current practices. The session will start with a 20 minute introduction on the topic, followed by panel discussion and audience interaction

Abstracts

Invited Speaker(s)

  • David Chadwick
  • Elaine Duncan
  • Nicholas J. Christiano/li>

Biomaterials for Therapeutic Drug Delivery 1

About

Biomaterials for Therapeutic Drug Delivery: Controlled release approaches have the potential to effectively treat a variety of medical conditions, while avoiding complications such as off-site toxicity and drug-resistance. Approaches can include localized, depot-based methods as well as targeted, systemic treatments. Controlled drug delivery can result from affinity interactions, bond cleavage, reservoir or diffusion-based control, and/or stimulus-responsive methodologies. This session will focus on the development of these drug delivery systems, which include nano and microparticles, hydrogels, scaffolds, and thin films, for applications including but not limited to regenerative medicine/tissue engineering, cancer treatments, microbial infections, autoimmune diseases, etc.

Abstracts

Engineered Biomaterials for Neural Applications 1

About

Engineered biomaterials for neural applications: Researchers are constantly developing and applying new biomaterials to challenging problems of the peripheral and central nervous systems. Engineered biomaterials are uniquely positioned for use in creating, testing, and regenerating neural tissue for better in vitro models of injury and disease, therapeutic treatments, understanding neural development, and mapping the brain. This session will focus on cutting edge research in neural biomaterials including fundamental material development through pre-clinical studies. These include big questions surrounding diseases and injuries spanning neurons, astrocytes, oligodendrocytes, microglia, and Schwann cells. Presentations will be highly interdisciplinary at the interfaces of biology, chemistry, materials science, engineering, and neuroscience. Target applications of these materials include neural injury, neurodegenerative diseases, stroke, diagnostics, brain-machine interfaces, and brain cancer.

Abstracts

Invited Speaker(s)